Salinas, P., Romaguera, R., Gómez-Lara, J., Brugaletta, S., Gómez-Menchero, A., Martín, P., . . . Fernández Ortiz, A. (2025). Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: Extended follow-up of the SUGAR randomised controlled trial.
Citación estilo ChicagoSalinas, Pablo, et al. Amphilimus-eluting Versus Zotarolimus-eluting Stents in Patients With Diabetes Mellitus and Coronary Artery Disease: Extended Follow-up of the SUGAR Randomised Controlled Trial. 2025.
Cita MLASalinas, Pablo, et al. Amphilimus-eluting Versus Zotarolimus-eluting Stents in Patients With Diabetes Mellitus and Coronary Artery Disease: Extended Follow-up of the SUGAR Randomised Controlled Trial. 2025.